Date of establishment: 2021
Capacity:
7,000 units per year
Products:
Сoronary sirolimuseluting stent systems and dilatation catheters for PCI
IHT Central Asia is a Kazakh-Spanish medical device manufacturing company.
Mission: IHT Central Asia develops and produces technological solutions for medical professionals, enabling the effective and affordable protection of patients’ health.
Strategy: The company’s strategy is based on knowledge exchange between the founders and leading healthcare professionals, using next-generation technologies and materials to develop innovative products:
Technology transfer from Iberhospitex (Spain) to Kazakhstan
Scientific and technical cooperation between the EU and Kazakhstan
Diversification and export to Central Asian countries (Uzbekistan, Kyrgyzstan, Tajikistan, Turkmenistan), as well as to the Caucasus and Southeast Asia
IHT Central Asia for Kazakhstan:
Import substitution and cost optimization for medical consumables
Transfer of advanced medical technologies to both Kazakhstan’s medical industry and healthcare sector
Participation of domestic healthcare professionals in international research alongside EU and US colleagues
Export to Central Asian countries: Uzbekistan, Kyrgyzstan, Tajikistan, Turkmenistan; and to Southeast Asian countries
Technology transfer agreements in the healthcare sector with companies from other developed countries